William Grossman
Interim Chief Medical Officer, Director · enGene Therapeutics Inc.
- 2025
- Sep 24, 2026
- 5
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as William Grossman. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Forbion Growth Opportunities Fund I Cooperatief U.A. - $8.01M in ENGN purchases and sales on record
- Ronald Harold Wilfred Cooper - $57K in ENGN purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is William Grossman?
William Grossman is a corporate insider, tracked as Interim Chief Medical Officer, Director of enGene Therapeutics Inc. (ENGN). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has William Grossman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has William Grossman been buying or selling stock?
Recorded transactions: 1 open-market purchase ($10K) and 0 open-market sales across all tracked filings.
